NEW YORK , Nov. 13, 2023 /PRNewswire-PRWeb/ -- Researchers at the Mount Sinai Center for Transformative Disease Modeling have released a groundbreaking study identifying 4,749 key gene clusters, termed "prognostic modules," that ...
— Cell Therapy Startup Spun Out of Baylor College of Medicine by Two CPRIT Scholars Awarded Non-Dilutive Funding for Novel Therapy for High-Need Cancer Patients — HOUSTON , Nov. 17, 2023 /PRNewswire/ -- March Biosciences (March ...
--Researchers found CAR T-cell therapy may serve as effective alternative for patients with these disorders -- PHILADELPHIA , Nov. 17, 2023 /PRNewswire/ -- Immunotherapies that target the CD20 antigen have revolutionized how ...
Seeking strategic partners for continued clinical development of PBCLN-010 with PBCLN-014, a lead investigational therapy comprising human milk sugars and gut bacteria found in nursing infants Recently published data demonstrated the ...
SEONGNAM, South Korea , Nov. 10, 2023 /PRNewswire/ -- Rznomics Inc., a South Korea based biopharmaceutical company specialized in the development of RNA-based gene therapeutics, announced today that it has entered into a clinical ...
LOS GATOS, Calif. , Nov. 9, 2023 /PRNewswire/ -- KDx Diagnostics, a pioneering medical device company known for its innovative noninvasive urine test for bladder cancer, the URO17Ò test, is thrilled to announce strategic partnerships with ...
Geisinger launches advanced AI risk model to enhance screening for lung cancer TEL AVIV, Israel and DANVILLE, Pa. , Nov. 8, 2023 /PRNewswire/ -- Medial EarlySign , a pioneering company developing AI-based clinical predictive ...
HENDERSON, Nev. , Nov. 6, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, and Veterinary Pathology Group (VPG), a leading high quality diagnostic laboratory, have joined ...
SHANGHAI , Nov. 4, 2023 /PRNewswire/ -- On October 26, 2023 , KangaBio announced that the U.S. FDA has granted official approval for their independent R&D clinical trial application (IND) for KGX101. KGX101 is a recombinant IL-12 Fc ...
The Mount Sinai Health System has received a $7 million grant from the Multiple Myeloma Research Foundation for a three-year project that aims to fast-track novel translational concepts to improve outcomes for people with high risk myeloma, ...
Ex-cigarette smokers who use e-cigarettes or vaping devices may face a higher risk of lung cancer compared to those who don't vape ( ). “This is the first large ...
Immunotherapy, which aims to harness the immune system to combat cancer, has proven effective for about 20% of cancer patients. Notable progress has been made, particularly in treating lung cancer and melanoma . Inspired by the significant potential ...
Researchers at The Australian National University (ANU) have developed a new AI tool DEPLOY that quickly and accurately classifies brain tumors. Dr. Danh-Tai Hoang emphasizes that precise diagnosis and categorization of tumors are crucial for ...
Breast cancer remains the predominant cancer among women globally, with escalating rates prompting a pressing quest for novel modifiable risk factors. Recent findings propose a correlation between increased childhood adiposity and decreased breast ...
Researchers have unveiled a fresh understanding of the genetic pathway involved in childhood cancer , providing optimism for personalized treatments. Their development of a stem cell model aims to probe the roots of neuroblastoma, a cancer ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers